Sign In
Buy OPY
$106.64
-4.06 (-3.67%)
At Close: Jul 31, 2026
Top analysts are betting on stocks like Mastercard and Nvidia right now into the second half
12:36pm, Sunday, 28'th Jun 2020
We used TipRanks analyst ranking service to pinpoint Wall Street's best-performing analysts.
The Manufacturers Life Insurance Company Has $29.96 Million Stake in T-Mobile Us Inc (NASDAQ:TMUS)
11:00am, Sunday, 28'th Jun 2020
The Manufacturers Life Insurance Company boosted its position in T-Mobile Us Inc (NASDAQ:TMUS) by 14.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Sec
FDx Advisors Inc. Cuts Holdings in ResMed Inc. (NYSE:RMD)
10:50am, Sunday, 28'th Jun 2020
FDx Advisors Inc. lessened its stake in ResMed Inc. (NYSE:RMD) by 9.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). T
Optimal Asset Management Inc. Takes Position in Service Co. International (NYSE:SCI)
10:05am, Sunday, 28'th Jun 2020
Optimal Asset Management Inc. bought a new stake in Service Co. International (NYSE:SCI) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Com
Skandinaviska Enskilda Banken AB publ Decreases Stock Position in W W Grainger Inc (NYSE:GWW)
09:58am, Sunday, 28'th Jun 2020
Skandinaviska Enskilda Banken AB publ decreased its position in shares of W W Grainger Inc (NYSE:GWW) by 5.3% in the first quarter, according to the company in its most recent Form 13F filing with the
Verus Capital Partners LLC Raises Stock Position in New Mountain Finance Corp. (NYSE:NMFC)
07:42am, Sunday, 28'th Jun 2020
Verus Capital Partners LLC lifted its position in New Mountain Finance Corp. (NYSE:NMFC) by 51.5% during the first quarter, according to the company in its most recent filing with the Securities & Exc
Kadmon (NYSE:KDMN) Earns “Buy” Rating from HC Wainwright
07:38am, Sunday, 28'th Jun 2020
Kadmon (NYSE:KDMN)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a report issued on Sunday, AnalystRatings.com reports. They currently have a $25.00 price target on the
Republic Services, Inc. (RSG) to Issue Quarterly Dividend of $0.41 on July 15th
07:38am, Sunday, 28'th Jun 2020
Republic Services, Inc. (NYSE:RSG) declared a quarterly dividend on Tuesday, April 28th, Zacks reports. Investors of record on Wednesday, July 1st will be given a dividend of 0.405 per share by the bu
Verus Capital Partners LLC Has $32,000 Holdings in H & R Block Inc (NYSE:HRB)
07:37am, Sunday, 28'th Jun 2020
Verus Capital Partners LLC cut its holdings in shares of H & R Block Inc (NYSE:HRB) by 31.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exc
Lemonade Prices IPO at $23.00-$26.00 Per Share (LMND)
02:42am, Sunday, 28'th Jun 2020
Lemonade (LMND) is planning to raise $270 million in an initial public offering on Thursday, July 2nd, IPO Scoop reports. The company plans to issue 11,000,000 shares at $23.00-$26.00 per share. In th
FY2024 EPS Estimates for Karuna Therapeutics (NASDAQ:KRTX) Increased by Oppenheimer
02:08am, Sunday, 28'th Jun 2020
Karuna Therapeutics (NASDAQ:KRTX) – Equities researchers at Oppenheimer lifted their FY2024 EPS estimates for Karuna Therapeutics in a report released on Wednesday, June 24th. Oppenheimer analyst J.
Lemonade (LMND) Announces July 2nd IPO
01:58am, Sunday, 28'th Jun 2020
Lemonade (LMND) plans to raise $270 million in an IPO on Thursday, July 2nd, IPO Scoop reports. The company plans to issue 11,000,000 shares at $23.00-$26.00 per share. In the last year, Lemonade gene
Intersect ENT Inc (NASDAQ:XENT) Forecasted to Earn Q2 2020 Earnings of ($0.59) Per Share
01:20am, Sunday, 28'th Jun 2020
Intersect ENT Inc (NASDAQ:XENT) – Equities researchers at Oppenheimer issued their Q2 2020 earnings per share estimates for shares of Intersect ENT in a report released on Tuesday, June 23rd. Oppenh
3 “Perfect 10” Stocks Under $10 With Big Upside Potential
12:00am, Sunday, 28'th Jun 2020
Stocks Analysis by Investing.com covering: Veru Inc, Rada Electronic Industries Ltd, Scpharmaceuticals Inc. Read Investing.com 's latest article on Investing.com
Crispr Therapeutics (NASDAQ:CRSP) Given New $89.00 Price Target at Oppenheimer
08:18am, Saturday, 27'th Jun 2020
Crispr Therapeutics (NASDAQ:CRSP) had its price objective hoisted by Oppenheimer from $80.00 to $89.00 in a research report released on Tuesday, The Fly reports. Oppenheimer currently has an outperfor
